Your browser doesn't support javascript.
loading
Advances in disease-modifying therapy of neuromyelitis optica spectrum disorders / 中华神经科杂志
Chinese Journal of Neurology ; (12): 1435-1446, 2023.
Article in Zh | WPRIM | ID: wpr-1029166
Responsible library: WPRO
ABSTRACT
Neuromyelitis optica spectrum disorders (NMOSD) are a group of autoimmune-mediated inflammatory demyelinating diseases of the central nervous system, characterized by optic nerve and spinal cord lesions, with high chance of recurrence and disability. Disease-modifying therapy, including immunosuppressants, monoclonal antibodies, stem cell transplantation etc., is the key to prevent recurrence. This article made a systematic review about the sequential treatment or prognosis of NMOSD by searching for the related articles published on PubMed from 2017 to 2022 to provide recommendations and references for disease-modifying therapy of NMOSD.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Neurology Year: 2023 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: Chinese Journal of Neurology Year: 2023 Type: Article